Search | Page 9 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... 12/31/2019 Bone Marrow Disease(s):  myelodysplastic syndromes (MDS) ...

    Clinical Trial last updated 05/04/2018 - 3:53pm.

  2. New study on SCT therapy for SAA, MDS patients

    ... the drug. Severe AA is a condition in which the bone marrow does not produce enough blood cells for the body, and hypoplastic ...

    Article last updated 08/22/2017 - 9:41am.

  3. Community Events

    ... other for mutual compassionate support. March for Marrow Walks Local organizers hold walks large and small in communities ... AAMDSIF supports to find the cure for bone marrow failure .  For your convenience, we also post events led by professionals ...

    Page last updated 04/10/2018 - 1:58pm.

  4. A Phase 2 Study of Tipifarnib in Subjects with Chronic Myelomonocytic Leukemia

    ... 12/01/2018 Bone Marrow Disease(s):  chronic myelomonocytic leukaemia ...

    Clinical Trial last updated 04/23/2018 - 2:51pm.

  5. Being able to help and empower people really appealed to me."

    ... the nursing field, do to help patients and families with bone marrow failure diseases. ...

    Patient Chronicle last updated 04/26/2018 - 10:08am.

  6. Marrow Community

    ... is a new, secure, online community for bone marrow failure patients and their families. It is sponsored and run by the ...

    Page last updated 04/04/2018 - 9:26am.

  7. Standardized High-Sensitivity Flow Cytometry Testing for Paroxysmal Nocturnal Hemoglobinuria in Children with Acquired Bone Marrow Failure Disorders: A Single Center U.S. Study

    ... documented in children, particularly those with acquired bone marrow failure disorders (ABMFD) - acquired aplastic anemia (AAA) ...

    Research Article last updated 06/26/2017 - 9:22am.

  8. The microenvironment in myelodysplastic syndromes: niche-mediated disease initiation and progression

    ... cells and represent the most common cause of acquired marrow failure. Hallmarked by ineffective hematopoiesis , dysplastic ... of MDS pathogenesis, evidence now identify the bone marrow microenvironment (BMME) as another key contributor to disease ...

    Research Article last updated 09/13/2017 - 8:25am.

  9. Take ACTION NOW! Support federal funding for bone marrow failure research

    ... a “Dear Colleague” letter requesting support for the Bone Marrow Failure Disease Research Program in the Department of Defense ...

    Article last updated 03/27/2017 - 11:33am.

  10. Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy.

    ... a negative impact on survival of advanced age, higher bone marrow blast count at LEN initiation, progression after LEN failure, and ...

    Research Article last updated 07/11/2017 - 10:11am.